Coherus_Logo_RGB_150.png
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
23 mai 2024 09h00 HE | Coherus BioSciences, Inc.
REDWOOD CITY, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual...
Cardiff.jpg
Cardiff Oncology to Present at Upcoming Investor Conferences in May
13 mai 2024 16h05 HE | Cardiff Oncology, Inc.
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
Immuneering-logo (1).png
Immuneering to Participate in the Cowen 44th Annual Health Care Conference
04 mars 2024 08h00 HE | Immuneering Corporation
CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for...
Logo-uniQure-MS-Word_Orange.jpg
uniQure to Participate in Multiple Upcoming Industry Conferences in March
02 mars 2023 07h05 HE | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 02, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
evelo-logo.png
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
01 mars 2023 06h00 HE | Evelo Biosciences, Inc.
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered anti-inflammatory...
Surface Logo_rgb[3].jpg
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
28 févr. 2023 16h15 HE | Surface Oncology, Inc.
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Icosavax_Logo.jpg
Icosavax to Participate in the Upcoming Healthcare Conferences
28 févr. 2023 08h00 HE | Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
exagen-logo-440x386-1.jpg
Exagen Inc. to Participate in Upcoming March Conferences
27 févr. 2023 09h00 HE | Exagen Inc.
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March...
Esperion Logo (primary).png
Esperion to Participate in the Cowen 43rd Annual Healthcare Conference
23 févr. 2023 08h00 HE | Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Sheldon Koenig, president and chief executive officer, will present at Cowen’s 43rd annual Health...
Logo_Large_DK_RGB.png
Solid Power to Present at Cowen 15th Annual Global Transportation & Sustainable Mobility Conference
01 sept. 2022 08h00 HE | Solid Power, Inc.
LOUISVILLE, Colo., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Solid Power, Inc. (“Solid Power”) (Nasdaq: SLDP), an industry-leading developer of all-solid-state battery cells for electric vehicles, today...